Want to see JP:3583 full AI Analyst Report?
3583 Stock Chart & Stats
¥1275.00
-¥2.00(-0.16%)
At close: 4:00 PM EST
¥1275.00
-¥2.00(-0.16%)
Day’s Range― - ―
52-Week Range¥1,125.00 - ¥1,453.00
Previous CloseN/A
Volume700.00
Average Volume (3M)1.25K
Market Cap
¥3.76B
Enterprise Value¥2.19B
Total Cash (Recent Filing)¥2.63B
Total Debt (Recent Filing)¥1.52B
Price to Earnings (P/E)6.5
Beta0.55
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.57%
Share Statistics
EPS (TTM)208.92
Shares Outstanding3,092,623
10 Day Avg. Volume1,550
30 Day Avg. Volume1,246
Financial Highlights & Ratios
PEG Ratio-110.90
Price to Book (P/B)0.57
Price to Sales (P/S)0.68
P/FCF Ratio-37.42
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative LeverageA materially lower debt-to-equity ratio improves financial flexibility and reduces interest burden, enabling the company to fund investment, weather revenue volatility, and preserve optionality for buybacks or dividends without stressing covenant or refinancing risk over the next several quarters.
Stable Profit MarginsConsistent net and EBITDA margins imply durable operating efficiency and some pricing or cost control advantages versus peers; these margin levels support ongoing profitability, internal funding for reinvestment, and the ability to sustain returns through moderate demand swings.
Proven Cash Generation In Good YearsThe business has shown it can convert earnings to cash in favorable periods, demonstrating capacity to fund capex, pay dividends, or reduce leverage when operations normalize; this structural ability underpins longer-term capital allocation flexibility.
Bears Say
Severe Top-line DeclineA near-50% revenue collapse is a structural threat to scale and operating leverage, eroding fixed-cost absorption, supplier leverage and store economics; if sustained, it can drive enduring margin pressure, asset write-downs and weaker returns over multiple quarters.
Volatile / Negative Free Cash FlowUnreliable cash conversion and a recent negative FCF year reduce the firm's ability to fund investments or shareholder distributions from operations, increase the likelihood of external financing in downturns, and constrain strategic responses to industry shifts over the medium term.
Modest Return On EquityAn ROE near 8% signals limited capital efficiency relative to stronger retail operators; modest returns constrain reinvestment capacity and make it harder to grow shareholder value, leaving the company vulnerable to better-capitalized competitors.
3583 FAQ
What was Aubex Corporation’s price range in the past 12 months?
Aubex Corporation lowest stock price was ¥1125.00 and its highest was ¥1453.00 in the past 12 months.
What is Aubex Corporation’s market cap?
Aubex Corporation’s market cap is ¥3.76B.
When is Aubex Corporation’s upcoming earnings report date?
Aubex Corporation’s upcoming earnings report date is Aug 07, 2026 which is in 8 days.
How were Aubex Corporation’s earnings last quarter?
Aubex Corporation released its earnings results on May 12, 2026. The company reported ¥40.61 earnings per share for the quarter, beating the consensus estimate of N/A by ¥40.61.
Is Aubex Corporation overvalued?
According to Wall Street analysts Aubex Corporation’s price is currently Overvalued.
Does Aubex Corporation pay dividends?
Aubex Corporation pays a Notavailable dividend of ¥35 which represents an annual dividend yield of 2.57%. See more information on Aubex Corporation dividends here
What is Aubex Corporation’s EPS estimate?
Aubex Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aubex Corporation have?
Aubex Corporation has 3,092,623 shares outstanding.
What happened to Aubex Corporation’s price movement after its last earnings report?
Aubex Corporation reported an EPS of ¥40.61 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.219%.
Which hedge fund is a major shareholder of Aubex Corporation?
Currently, no hedge funds are holding shares in JP:3583
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aubex Corporation
AuBEX CORPORATION is a global manufacturer and distributor, focusing on precision nibs and essential medical equipment. The company's nibs are meticulously crafted from diverse materials such as polyester, nylon, acrylic, and various types of plastics. These nibs find application in a wide array of products, from stationery used for writing, marking, painting, and presentations, to components for PC peripherals and industrial machinery. AuBEX also innovates in the beauty sector, producing specialized cosmetic applicators like porous tips, PBT brush tips, feeders, and other cosmetic tips. In the medical field, the company provides critical equipment and components, including pressure infusion devices and angiography guide wires, serving public, private university, and other hospitals. Founded in 1892 in Tokyo, Japan, the company was initially named Tokyo hat Co., Ltd. before rebranding as AuBEX CORPORATION in 1985.
Technical Analysis
Chukyo Iyakuhin Co., Ltd.
―
HOUSE OF ROSE Co.,Ltd.
―
POPLAR Co., Ltd.
―
Okuwa Co., Ltd.
―
Izutsuya Co., Ltd.
―